Sign In
Buy AMPE
$0.183
+0 (+0%)
At Close: Jun 03, 2026
Here is What Hedge Funds Think About Ampio Pharmaceuticals, Inc. (AMPE)
12:57am, Tuesday, 24'th Dec 2019
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking. Hedge funds underperform because their net exposure in only 40-70% and they charge exo
Roth Capital Initiates Coverage On Ampio Pharmaceuticals with Buy Rating, Announces $4 Price Target
11:38am, Thursday, 19'th Dec 2019Ampio Pharmaceuticals shares are trading higher after Roth Capital Partners initiated coverage on the stock with a Buy rating.
09:15pm, Wednesday, 18'th Dec 2019Ampio Provides Update on AP-013 Phase III Clinical Trial and Annual Meeting Conference Call Number
01:30pm, Wednesday, 04'th Dec 2019
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a Special Protocol Assessment (SPA) Phase III clinical trial titled "Evaluating the Efficacy
Ampio Provides Update on AP-…–' Phase III Clinical Trial and Annual Meeting Conference ...
12:00am, Wednesday, 04'th Dec 2019Private Capital Management Llc Buys Ampio Pharmaceuticals Inc, AT&T Inc, Comcast Corp, ...
12:00am, Wednesday, 16'th Oct 2019Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility
12:30pm, Thursday, 10'th Oct 2019
ENGLEWOOD, Colo., Oct. 10, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a Special Protocol Assessment (SPA) Phase III
Ampio Pharma Offers Update On Continued Progress Of AP-013 Phase 3 Trial, Manufacturing Facility
12:00am, Thursday, 10'th Oct 2019Ampio Retains Legal Counsel for Transaction Advisory Committee
12:30pm, Wednesday, 18'th Sep 2019
ENGLEWOOD, Colo., Sept. 18, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a Special Protocol Assessment (SPA) phase t
Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial
12:30pm, Tuesday, 17'th Sep 2019
ENGLEWOOD, Colo. , Sept. 17, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) today announced the progress to date in the Company's special protocol assessment (SPA) phase t
Ampio Pharmaceuticals Retains Financial Advisor and Appoints Transaction Advisory Committee
12:30pm, Thursday, 22'nd Aug 2019
ENGLEWOOD, Colo., Aug. 22, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a special protocol assessment (SPA) phase th
